tumor necrosis factor alpha (TNF

Diagnostic tumor necrosis factor alpha (TNF

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-h-TNF-Ag01 Recombinant human TNF/TNF 3090
GMP-h-TNF-Ab01 Anti-human TNF/TNF 1953
GMP-h-TNF-Ab02 Anti-human TNF/TNF 1953
GMP-h-TNF-Ab03 Anti-human TNF/TNF 1953
GMP-h-TNF-Ab04 Anti-human TNF/TNF 1953

Size： 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-h-TNF-Ag01
Product Name Recombinant human TNF/TNF
Target/Biomarker tumor necrosis factor alpha(TNF)
Alias of Target/Biomarker DIF, TNF-alpha, TNFA, TNFSF2, TNLG1F
Expression platform mammalian
Isotypes Recombinant Antigen
Bioactivity validation tumor necrosis factor alpha (TNF) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in TNF level test of Inflammation/autoimmune/inflammatory disease (rheumatoid arthritis, ankylosing spondylitis, and Crohn) and related syndrome evaluation.
Products description Recombinant human TNF/TNF was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-h-TNF-Ab01, GMP-h-TNF-Ab02, GMP-h-TNF-Ab03, GMP-h-TNF-Ab04
Product Name Anti-human TNF/TNF
Target/Biomarker tumor necrosis factor alpha(TNF)
Alias of Target/Biomarker DIF, TNF-alpha, TNFA, TNFSF2, TNLG1F
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Human tumor necrosis factor alpha (TNF) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other tumor necrosis factor alpha (TNF) antibodies in TNF level test of Inflammation/autoimmune/inflammatory disease (rheumatoid arthritis, ankylosing spondylitis, and Crohn) and related syndrome evaluation.
Tag mFc
Products description Anti-human TNF/TNF is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    The master pro-inflammatory cytokine, tumour necrosis factor (TNF), has been shown to modulate multiple signalling pathways, with wide-ranging downstream effects. TNF plays a vital role in the typical immune response through the regulation of a number of pathways encompassing an immediate inflammatory reaction with significant innate immune involvement as well as cellular activation with subsequent proliferation and programmed cell death or necrosis. As might be expected with such a broad spectrum of cellular effects and complex signalling pathways, TNF has also been implicated in a number of disease states, such as rheumatoid arthritis, ankylosing spondylitis, and Crohn



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    John Garcia 2024-02-20 10:39:17
    High stability and demanding data quality are evidenced from the TNF antibody, appropriate for Lateral Flow Immunoassay (LFIA). It also improves diagnosing capability of a disease in relation to symptoms presented by the patient.

    Leave a comment